Figure 2

Stages of the TREAT-ME1 study. The TREAT-ME1 trial will be conducted in two stages, which are interrupted by an interim-analysis. Phase II will include two patient groups. Group 1 will be treated by the same treatment schedule as in phase I. Group 2 will consist of patient that are eligible for surgical resection of the tumor but that need neoadjuvant therapy.